PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM

OMIM Update List for February, 2002

Please send your questions to the NCBI Help Desk.

February 28, 2002

New Entries:

606728 SERUM DEPRIVATION RESPONSE PHOSPHATIDYLSERINE-BINDING PROTEIN; SDPR
606729 OXYSTEROL-BINDING PROTEIN 2; OSBP2
606730 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A
606731 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2; OSBPL2
606732 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3; OSBPL3
606733 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5; OSBPL5
606734 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6; OSBPL6
606735 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7
606736 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8; OSBPL8
606737 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9; OSBPL9
606738 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10; OSBPL10
606739 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11; OSBPL11

Changed Entries:

110700 BLOOD GROUP--DUFFY SYSTEM; FY
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1
124092 INTERLEUKIN 10; IL10
130050 EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT; EDS4
137164 GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2
141250 HEME OXYGENASE 1; HMOX1
147185 IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108
173470 INTEGRIN, BETA-3; ITGB3
176943 FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2
188540 THYROID-STIMULATING HORMONE, BETA CHAIN; TSHB
188550 THYROID CARCINOMA, PAPILLARY
191160 TUMOR NECROSIS FACTOR; TNF
215700 CITRULLINEMIA, CLASSIC
222600 DIASTROPHIC DYSPLASIA
273800 THROMBASTHENIA OF GLANZMANN AND NAEGELI
308230 IMMUNODEFICIENCY WITH HYPER-IgM
601407 DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2
603384 SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1
606718 SOLUTE CARRIER FAMILY 26, MEMBER 2; SLC26A2
606728 SERUM DEPRIVATION RESPONSE PHOSPHATIDYLSERINE-BINDING PROTEIN; SDPR
606729 OXYSTEROL-BINDING PROTEIN 2; OSBP2
606730 OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A

February 27, 2002

New Entries:

606718 SOLUTE CARRIER FAMILY 26, MEMBER 2; SLC26A2
606722 NEUROCALCIN, DELTA; NCALD
606724 MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE
606725 CLN6 GENE; CLN6
606726 SOLUTE CARRIER FAMILY 12, MEMBER 5; SLC12A5
606727 NK2, DROSOPHILA, HOMOLOG OF, C; NKX2C
Clinical Synopsis for 602579 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib
Clinical Synopsis for 603147 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic
Clinical Synopsis for 603585 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix

Changed Entries:

102670 MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1
103900 HYPERALDOSTERONISM, FAMILIAL, TYPE I
107910 CYTOCHROME P450, SUBFAMILY XIX; CYP19
118485 CYTOCHROME P450, SUBFAMILY XIA; CYP11A
119800 CLUBFOOT
133440 EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E
142622 HIPPOCALCIN; HPCA
154500 TREACHER COLLINS-FRANCESCHETTI SYNDROME 1; TCOF1
161561 INTERLEUKIN 12B; IL12B
176761 PROLACTIN RECEPTOR; PRLR
176948 MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1
182455 SOMATOSTATIN RECEPTOR 5; SSTR5
188470 THYROID CARCINOMA, FOLLICULAR; FTC
201710 LIPOID CONGENITAL ADRENAL HYPERPLASIA
204500 CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE TYPE; CLN2
222600 DIASTROPHIC DYSPLASIA
226900 EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
251450 MICROMELIC DWARFISM WITH VERTEBRAL AND METAPHYSEAL ABNORMALITIES AND
256050 NEONATAL OSSEOUS DYSPLASIA I
475000 GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
600207 HIPPOCALCIN-LIKE 1; HPCAL1
600354 SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600495 EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1; EIF4G1
600837 GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GDNF
600972 ACHONDROGENESIS, TYPE IB; ACG1B
601627 SURVIVAL OF MOTOR NEURON 2, CENTROMERIC; SMN2
601780 CEROID LIPOFUSCINOSIS, NEURONAL, LATE-INFANTILE, VARIANT
601795 MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3
602325 EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2
602579 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib
603005 3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
603147 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic
603585 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix
604309 SOLUTE CARRIER FAMILY 13, MEMBER 4; SLC13A4
605069 G PROTEIN-COUPLED RECEPTOR KINASE 7; GPRK7
605646 SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
606193 SOLUTE CARRIER FAMILY 13, MEMBER 1; SLC13A1
606227 MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP
606719 MELANOMA-PANCREATIC CANCER SYNDROME
606722 NEUROCALCIN, DELTA; NCALD
606723 MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5
Clinical Synopsis for 203450 ALEXANDER DISEASE
Clinical Synopsis for 209900 BARDET-BIEDL SYNDROME; BBS
Clinical Synopsis for 212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
Clinical Synopsis for 236700 MCKUSICK-KAUFMAN SYNDROME; MKKS
Clinical Synopsis for 249000 MECKEL SYNDROME, TYPE 1; MKS1
Clinical Synopsis for 603147 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic

February 26, 2002

New Entries:

300379 PUTATIVE RING ZINC FINGER PROTEIN NY-REN-43 ANTIGEN
300380 CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2; CTPS2
606608 YES-ASSOCIATED PROTEIN 1, 65-KD; YAP1
606719 MELANOMA-PANCREATIC CANCER SYNDROME
606721 LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION
606723 MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5

Changed Entries:

122500 CORTICOSTEROID-BINDING GLOBULIN; CBG
124080 CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125853 DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
131100 MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
186930 T-CELL ANTIGEN RECEPTOR, BETA SUBUNIT; TCRB
202010 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 11-@BETA-HYDROXYLASE DEFICIENCY
260350 PANCREATIC CARCINOMA
600160 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
600289 MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600630 UV-SENSITIVE SYNDROME; UVS
602195 HEAT-SHOCK 27-KD PROTEIN 1; HSPB1
603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2
603859 SOLUTE CARRIER FAMILY 25, MEMBER 13; SLC25A13
604751 ZINC FINGER PROTEIN 266; ZNF266
604752 ZINC FINGER PROTEIN 267; ZNF267
605504 KALLIKREIN 9; KLK9
605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET
606655 LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 8
606716 N-ACETYLTRANSFERASE 8; NAT8
606719 MELANOMA-PANCREATIC CANCER SYNDROME
606721 LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION
Clinical Synopsis for 209900 BARDET-BIEDL SYNDROME; BBS
Clinical Synopsis for 236700 MCKUSICK-KAUFMAN SYNDROME; MKKS

February 25, 2002

New Entries:

300378 RADIAL RAY DEFICIENCY, X-LINKED
606710 LIPOMA HMGIC FUSION PARTNER; LHFP
606711 SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
606712 SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
606713 VAN DER WOUDE SYNDROME 2
606714 PROLINE-RICH 2; PROL2
606715 ACID-SENSING ION CHANNEL 4
606716 N-ACETYLTRANSFERASE 8; NAT8
606717 XIAP-ASSOCIATED FACTOR 1

Changed Entries:

118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA; PNKD
119300 VAN DER WOUDE SYNDROME; VWS
120150 COLLAGEN, TYPE I, ALPHA-1; COL1A1
142410 TRANSCRIPTION FACTOR 1; TCF1
187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;
209850 AUTISM, SUSCEPTIBILITY TO, 1; AUTS1
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
252900 MUCOPOLYSACCHARIDOSIS TYPE IIIA
252920 MUCOPOLYSACCHARIDOSIS TYPE IIIB
253200 MUCOPOLYSACCHARIDOSIS TYPE VI
600374 BBS4 GENE; BBS4
600698 HIGH MOBILITY GROUP PROTEIN ISOFORM I-C; HMGIC
601767 HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
602081 SPECIFIC LANGUAGE IMPAIRMENT; SLI
603315 FREQUENIN, DROSOPHILA, HOMOLOG OF; FREQ
604999 SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1
605270 N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH
606650 GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A
606651 GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B
606716 N-ACETYLTRANSFERASE 8; NAT8
Clinical Synopsis for 600374 BBS4 GENE; BBS4

February 25, 2002

Changed Entries:

134638 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 6; TNFSF6
181750 SCLERODERMA, FAMILIAL PROGRESSIVE
238310 AMINOMETHYLTRANSFERASE; AMT
238330 GLYCINE CLEAVAGE SYSTEM H PROTEIN; GCSH
310400 MYOTUBULAR MYOPATHY 1; MTM1
600259 POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 2; PMS2
603598 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10; TNFSF10

February 22, 2002

New Entries:

606709 PROTEASE, SERINE, 12; PRSS12

Changed Entries:

104760 AMYLOID BETA A4 PRECURSOR PROTEIN; APP
109770 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1; CEACAM1
116845 CATHEPSIN S; CTSS
137360 GENOCHONDROMATOSIS
142790 CD74 ANTIGEN; CD74
142960 HOMEO BOX B5; HOXB5
147250 SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI
148030 KERATIN 15; KRT15
148040 KERATIN 5; KRT5
148066 KERATIN 14; KRT14
161200 NAIL-PATELLA SYNDROME; NPS
164210 HEMIFACIAL MICROSOMIA; HFM
164785 MOUSE DOUBLE MINUTE 2 HOMOLOG; MDM2
166000 ENCHONDROMATOSIS, MULTIPLE
166300 OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH NEPHROPATHY
168468 PARATHYROID HORMONE RECEPTOR 1; PTHR1
179520 RAS-RELATED PROTEIN 1A; RAP1A
187011 SMALL INDUCIBLE CYTOKINE A5; SCYA5
188410 THYMOCYTE ANTIGEN CD1D; CD1D
225795 MOVED TO 166000
238300 GLYCINE DECARBOXYLASE; GLDC
256730 CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
300500 ALBINISM, OCULAR, TYPE I; OA1
311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
600483 FIBROBLAST GROWTH FACTOR 8; FGF8
600508 NCK ADAPTOR PROTEIN 1; NCK1
600805 LAMININ, ALPHA-3; LAMA3
601664 U5 snRNP-SPECIFIC PROTEIN, 200-KD
603177 VESICLE-ASSOCIATED MEMBRANE PROTEIN 8; VAMP8
603288 KERATOCAN; KERA
604520 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14
604895 T-BOX 21; TBX21
604978 CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 5; CPSF5
605171 p53-INDUCED GENE 3
605369 AIRWAY TRYPSIN-LIKE PROTEASE
605658 INTERLEUKIN 17E; IL17E
605899 GLYCINE ENCEPHALOPATHY; GCE
606706 TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606708 SPLIT-HAND/FOOT MALFORMATION 5
606709 PROTEASE, SERINE, 12; PRSS12

February 21, 2002

New Entries:

300375 CARBOHYDRATE SULFOTRANSFERASE 7; CHST7
606702 POLYCYSTIC KIDNEY AND HEPATIC DISEASE 1 GENE; PKHD1
606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA
606704 G PROTEIN-COUPLED RECEPTOR 75; GPR75
606705 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 36; DFNA36
606706 TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606707 TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 2; TMC2
606708 SPLIT-HAND/FOOT MALFORMATION 5

Changed Entries:

118700 CHOREA, HEREDITARY BENIGN; BCH
125647 DESMOPLAKIN; DSP
133171 ERYTHROPOIETIN RECEPTOR; EPOR
142830 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B
142857 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1
154870 GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, MATRIX; MGP
168820 PARAOXONASE 1; PON1
183600 SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
186000 SYNDACTYLY, TYPE II
191315 NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1
204400 REMOVED FROM DATABASE
209850 AUTISTIC DISORDER
213000 CEREBELLAR HYPOPLASIA
213200 CEREBELLAR ATAXIA 1; CLA1
254800 MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
263200 POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
301000 WISKOTT-ALDRICH SYNDROME; WAS
308230 IMMUNODEFICIENCY WITH HYPER-IgM
313350 SPLIT-HAND/FOOT MALFORMATION 2; SHFM2
313700 ANDROGEN RECEPTOR; AR
600046 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600095 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
600173 JANUS KINASE 3; JAK3
600974 DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7; DFNB7
601908 G PROTEIN-COUPLED RECEPTOR 20; GPR20
603273 TUMOR PROTEIN p63
603499 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A; TNFRSF11A
603799 CARBOHYDRATE SULFOTRANSFERASE 3; CHST3
604221 ACTIN-RELATED PROTEIN 2; ACTR2
605035 WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 1; WASF1
605257 ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA
605289 SPLIT-HAND/FOOT MALFORMATION 4; SHFM4
606265 E1A-BINDING PROTEIN, 400-KD; EP400
606700 MIDNOLIN, MOUSE, HOMOLOG OF; MIDN
606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA
606704 G PROTEIN-COUPLED RECEPTOR 75; GPR75
606706 TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606708 SPLIT-HAND/FOOT MALFORMATION 5
Clinical Synopsis for 204400 REMOVED FROM DATABASE

February 20, 2002

New Entries:

606698 SRY-BOX 30
606699 HELICASE WITH ZINC FINGER DOMAIN; HELZ
606700 MIDNOLIN, MOUSE, HOMOLOG OF; MIDN
606701 DRG11, RAT, HOMOLOG OF

Changed Entries:

107265 CD19 ANTIGEN; CD19
107470 INTERFERON, GAMMA, RECEPTOR 1; IFNGR1
136530 FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB
138130 GLUTAMATE DEHYDROGENASE 1; GLUD1
139191 GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR
139250 GROWTH HORMONE 1; GH1
143890 HYPERCHOLESTEROLEMIA, FAMILIAL
146732 INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3
156240 MESOTHELIOMA, MALIGNANT
159555 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
165120 V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN
177020 PROTEINASE 3; PRTN3
182115 PLECKSTRIN HOMOLOGY, SEC7, AND COILED-COIL DOMAINS PROTEIN 1; PSCD1
193400 VON WILLEBRAND DISEASE
209950 ATYPICAL MYCOBACTERIOSIS, FAMILIAL
222600 DIASTROPHIC DYSPLASIA
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1
314200 THYROXINE-BINDING GLOBULIN OF SERUM; TBG
600953 INTERLEUKIN 18; IL18
601487 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
603827 BCL2-LIKE 11; BCL2L11
605268 JUNCTOPHILIN 3; JPH3
605598 DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18
605987 PROTEIN INHIBITOR OF ACTIVATED STAT3
606592 VANIN 3; VNN3
606697 ZINC FINGER PROTEIN ZK1
606698 SRY-BOX 30
606699 HELICASE WITH ZINC FINGER DOMAIN; HELZ
Clinical Synopsis for 212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
Clinical Synopsis for 248700 MARDEN-WALKER SYNDROME
Clinical Synopsis for 269150 SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME
Clinical Synopsis for 276700 TYROSINEMIA, TYPE I

February 19, 2002

New Entries:

606697 ZINC FINGER PROTEIN ZK1

Changed Entries:

103275 ADRENOMEDULLIN; ADM
107470 INTERFERON, GAMMA, RECEPTOR 1; IFNGR1
114190 CALCITONIN RECEPTOR-LIKE GENE; CALCRL
125850 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1
143850 ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE
160900 DYSTROPHIA MYOTONICA 1
161560 INTERLEUKIN 12A; IL12A
161561 INTERLEUKIN 12B; IL12B
168860 PATELLA APLASIA-HYPOPLASIA; PTLAH
171300 PHEOCHROMOCYTOMA
175100 ADENOMATOUS POLYPOSIS OF THE COLON; APC
204200 CEROID LIPOFUSCINOSIS, NEURONAL 3, JUVENILE; CLN3
218040 COSTELLO SYNDROME
227400 FACTOR V DEFICIENCY
229300 FRIEDREICH ATAXIA 1; FRDA
248300 MAL DE MELEDA
300248 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE
308300 INCONTINENTIA PIGMENTI; IP
314200 THYROXINE-BINDING GLOBULIN OF SERUM; TBG
600044 THROMBOPOIETIN; THPO
600160 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
600281 HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
601224 POTOCKI-SHAFFER SYNDROME
601417 17-@BETA-HYDROXYSTEROID DEHYDROGENASE VIII; HSD17B8
601611 SOLUTE CARRIER FAMILY 14, MEMBER 2; SLC14A2
602668 DYSTROPHIA MYOTONICA 2; DM2
602671 GLUCOSE-6-PHOSPHATE TRANSPORTER 1; G6PT1
602703 KATANIN, p80 SUBUNIT, B1; KATNB1
602858 7-@DEHYDROCHOLESTEROL REDUCTASE; DHCR7
603101 CARBOXYPEPTIDASE B2, PLASMA; CPB2
603171 NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8;
603945 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5
604396 SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1
604687 PROSTAGLANDIN D2 RECEPTOR; PTGDR
604837 G PROTEIN-COUPLED RECEPTOR 44; GPR44
605154 RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RAMP2
605307 ADRENOMEDULLIN RECEPTOR; ADMR
605821 ERYTHROID-ASSOCIATED FACTOR; ERAF
606454 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2
606516 MUSCLEBLIND-LIKE PROTEIN; MBNL
Clinical Synopsis for 114290 CAMPOMELIC DYSPLASIA
Clinical Synopsis for 230400 GALACTOSEMIA
Clinical Synopsis for 247200 MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
Clinical Synopsis for 276700 TYROSINEMIA, TYPE I

February 19, 2002

New Entries:

606592 VANIN 3; VNN3
606612 MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C
606694 NUCLEOPORIN, 155-KD; NUP155
606695 OPSIN 3; OPN3
606696 KATANIN, p60 SUBUNIT, A1; KATNA1

Changed Entries:

100730 CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG
106210 PAIRED BOX GENE 6; PAX6
118220 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
118825 CHOROIDEREMIA-LIKE; CHML
126452 DOPAMINE RECEPTOR D4; DRD4
144110 HYPERHIDROSIS PALMARIS ET PLANTARIS
146880 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1
147450 SUPEROXIDE DISMUTASE 1; SOD1
153700 MACULAR DYSTROPHY, VITELLIFORM; VMD2
176730 INSULIN; INS
180849 RUBINSTEIN SYNDROME
191050 TRYPTOPHANYL-tRNA SYNTHETASE; WARS
200990 ACROCALLOSAL SYNDROME; ACLS
201475 ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF
209900 BARDET-BIEDL SYNDROME; BBS
214500 CHEDIAK-HIGASHI SYNDROME; CHS1
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
225790 ENCEPHALOCLASTIC PROLIFERATIVE VASCULOPATHY; EPV
227650 FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
232300 GLYCOGEN STORAGE DISEASE II
235200 HEMOCHROMATOSIS; HFE
236200 HOMOCYSTINURIA
242860 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
268100 ENHANCED S-CONE SYNDROME; ESCS
277900 WILSON DISEASE
300079 BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4; BIRC4
300181 X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
303600 COFFIN-LOWRY SYNDROME; CLS
308840 L1 CELL ADHESION MOLECULE; L1CAM
312750 RETT SYNDROME; RTT
314670 X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
600289 MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600424 SOLUTE CARRIER FAMILY 19, MEMBER 1; SLC19A1
600442 AQUAPORIN 5; AQP5
600597 PHOSPHOLIPASE C-LIKE 1; PLCL1
600725 SONIC HEDGEHOG; SHH
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22
601283 DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1
601556 ATAXIN 1; ATX1
601618 SRY-BOX 18; SOX18
602386 ZINC FINGER PROTEIN 212; ZNF212
602615 TAK1-BINDING PROTEIN 1
602703 KATANIN, p80 SUBUNIT, B1; KATNB1
603171 NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8;
603538 KYNURENINE 3-MONOOXYGENASE; KMO
603570 VANIN 1; VNN1
603948 NUCLEOPORIN, 153-KD; NUP153
603972 ZINC FINGER PROTEIN 43; ZNF43
604290 ACERULOPLASMINEMIA
604485 NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3; NR2E3
604748 SRY-BOX 13; SOX13
604975 SRY-BOX 5; SOX5
605286 CALPAIN 10; CAPN10
606592 VANIN 3; VNN3
606618 DUAL-SPECIFICITY PHOSPHATASE 14; DUSP14
606620 B-LYMPHOCYTE ACTIVATOR, MACROPHAGE-EXPRESSED
606696 KATANIN, p60 SUBUNIT, A1; KATNA1

February 16, 2002

Changed Entries:

603948 NUCLEOPORIN, 153-KD; NUP153
604646 NUCLEOPORIN, 50-KD; NUP50
605815 NUCLEOPORIN, 62-KD; NUP62

February 15, 2002

New Entries:

606693 PALLIDOPYRAMIDAL DEGENERATION WITH SUPRANUCLEAR UPGAZE PARESIS AND

Changed Entries:

137760 GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
146710 INTERLEUKIN 2 RECEPTOR, BETA; IL2RB
147680 INTERLEUKIN 2; IL2
147730 INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA
158120 MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14
168820 PARAOXONASE 1; PON1
171790 PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP
211600 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1; PFIC1
226650 EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE
300292 FORKHEAD BOX P3
308380 INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG
600805 LAMININ, ALPHA-3; LAMA3
600832 ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A
601265 NODAL, MOUSE, HOMOLOG OF; NODAL
602033 ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1
602397 ATPase, CLASS I, TYPE 8B, MEMBER 1; ATP8B1
602552 NUCLEOPORIN, 88-KD; NUP88
602695 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
603527 DIPHTHAMIDE BIOSYNTHESIS PROTEIN 2, S. CEREVISIAE, HOMOLOG-LIKE 1;
604740 SOLUTE CARRIER FAMILY 39, ZINC TRANSPORTER, MEMBER 1; SLC39A1
605815 NUCLEOPORIN, 62-KD; NUP62
605914 TYPE I TRANSMEMBRANE PROTEIN FN14
606178 HEDGEHOG-INTERACTING PROTEIN; HHIP
606265 TRINUCLEOTIDE REPEAT-CONTAINING GENE 12; TNRC12
606273 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3
606655 GLYCOPROTEIN HORMONE, ALPHA-2; GPHA2
606677 LECTIN, C-TYPE, SUPERFAMILY MEMBER 11; CLECSF11
606693 PALLIDOPYRAMIDAL DEGENERATION WITH SUPRANUCLEAR UPGAZE PARESIS AND

February 14, 2002

New Entries:

606690 LYMPHANGIOLEIOMYOMATOSIS; LAM
Clinical Synopsis for 606688 PRION DISEASE WITH PROTRACTED COURSE

Changed Entries:

107400 PROTEASE INHIBITOR 1; PI
118955 CLATHRIN, HEAVY POLYPEPTIDE; CLTC
137760 GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
143100 HUNTINGTON DISEASE; HD
164160 LEPTIN; LEP
176270 PRADER-WILLI SYNDROME; PWS
176640 PRION PROTEIN; PRNP
181430 SCAPULOPERONEAL MYOPATHY; SPM
185800 SYMPHALANGISM, PROXIMAL; SYM1
191092 TUBEROUS SCLEROSIS 2 GENE; TSC2
191290 TYROSINE HYDROXYLASE; TH
192430 VELOCARDIOFACIAL SYNDROME
202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
235200 HEMOCHROMATOSIS; HFE
254800 MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
261600 PHENYLKETONURIA
300017 FILAMIN A; FLNA
309550 FRAGILE SITE MENTAL RETARDATION 1; FMR1
600119 SARCOGLYCAN, ALPHA; SGCA
600242 CHEMOKINE (C-C) RECEPTOR 7; CCR7
600702 SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
600797 INSULIN RECEPTOR SUBSTRATE 2; IRS2
601007 LEPTIN RECEPTOR; LEPR
601026 ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT; AP2A1
601145 CYSTATIN B; CSTB
601628 MODIFIER OF VON WILLEBRAND FACTOR
601767 HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602432 OPTINEURIN; OPTN
602737 SMALL INDUCIBLE CYTOKINE SUBFAMILY A, MEMBER 21; SCYA21
602768 DELTA-LIKE 3; DLL3
602991 NOGGIN, MOUSE, HOMOLOG OF; NOG
603803 DACHSHUND, DROSOPHILA, HOMOLOG OF; DACH
604592 T CELL IMMUNE REGULATOR 1; TCIRG1
604655 MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14
604862 LECTIN, C-TYPE, LANGERHANS CELL-SPECIFIC
605284 TUBEROUS SCLEROSIS 1 GENE; TSC1
606688 PRION DISEASE WITH PROTRACTED COURSE
Clinical Synopsis for 176640 PRION PROTEIN; PRNP
Clinical Synopsis for 191092 TUBEROUS SCLEROSIS 2 GENE; TSC2
Clinical Synopsis for 191100 TUBEROUS SCLEROSIS; TS

February 13, 2002

New Entries:

606688 PRION DISEASE WITH PROTRACTED COURSE
606689 GLAUCOMA 1, OPEN ANGLE, B; GLC1B

Changed Entries:

106150 ANGIOTENSIN I; AGT
135630 INTEGRIN, BETA-1; ITGB1
137440 GERSTMANN-STRAUSSLER DISEASE; GSD
137750 GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET; JOAG
137760 GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
147280 INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR; IGF2R
147450 SUPEROXIDE DISMUTASE 1; SOD1
147557 INTEGRIN, BETA-4; ITGB4
170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
171050 ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
176640 PRION PROTEIN; PRNP
188340 THYMOCYTE ANTIGEN CD1C; CD1C
188360 THYMOCYTE ANTIGEN CD1B; CD1B
188370 THYMOCYTE ANTIGEN CD1A; CD1A
188410 THYMOCYTE ANTIGEN CD1D; CD1D
188411 THYMOCYTE ANTIGEN CD1E; CD1E
248600 MAPLE SYRUP URINE DISEASE, TYPE IA
256550 NEURAMINIDASE DEFICIENCY
276700 TYROSINEMIA, TYPE I
300005 METHYL-CpG-BINDING PROTEIN 2; MECP2
601253 CAVEOLIN 3; CAV3
601652 MYOCILIN; MYOC
601682 GLAUCOMA 1, OPEN ANGLE, C; GLC1C
602429 GLAUCOMA 1, OPEN ANGLE, D; GLC1D
602432 OPTINEURIN; OPTN
602575 LIM HOMEO BOX TRANSCRIPTION FACTOR 1, BETA; LMX1B
602608 SOLUTE CARRIER FAMILY 22, MEMBER 2; SLC22A2
602851 VERY LARGE G PROTEIN-COUPLED RECEPTOR 1
603009 DYSFERLIN; DYSF
603797 CARBOHYDRATE SULFOTRANSFERASE 1; CHST1
603799 CARBOHYDRATE SULFOTRANSFERASE 3; CHST3
604842 SOLUTE CARRIER FAMILY 22, MEMBER 3; SLC22A3
604893 ANTISENSE IGF2R
605264 SH3 DOMAIN PROTEIN 5; SH3D5
606118 HERMANSKY-PUDLAK SYNDROME GENE 3; HPS3
606657 GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO
606683 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6
606684 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7
Clinical Synopsis for 170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA

February 12, 2002

New Entries:

606685 CARDIOMYOPATHY, DILATED, 1L; CMD1L
606686 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1
606687 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4

Changed Entries:

102578 ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML
104175 GLYCOPROTEIN ALPHA-GALACTOSYLTRANSFERASE 1; GGTA1
113705 BREAST CANCER, TYPE 1; BRCA1
115200 CARDIOMYOPATHY, DILATED, 1A; CMD1A
143100 HUNTINGTON DISEASE; HD
147450 SUPEROXIDE DISMUTASE 1; SOD1
169100 CHAR SYNDROME
170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
231300 GLAUCOMA 3, PRIMARY INFANTILE, A; GLC3A
231500 MOVED TO 231300
301000 WISKOTT-ALDRICH SYNDROME; WAS
600393 FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1; FEN1
600409 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
601069 ZINC FINGER PROTEIN 239; ZNF239
601411 SARCOGLYCAN, DELTA; SGCD
601487 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
603078 CHECKPOINT, S. POMBE, HOMOLOG OF, 1; CHEK1
604065 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G
606118 HERMANSKY-PUDLAK SYNDROME GENE 3; HPS3
606519 PHACE ASSOCIATION
606665 OPSIN 4; OPN4
Clinical Synopsis for 231500 MOVED TO 231300

February 11, 2002

New Entries:

606681 NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
606682 HERMANSKY-PUDLAK SYNDROME GENE 4; HPS4
606683 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6
606684 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7

Changed Entries:

116790 CATECHOL-O-METHYLTRANSFERASE; COMT
137750 GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET; JOAG
147870 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2
164230 OBSESSIVE-COMPULSIVE DISORDER 1; OCD1
173360 PLASMINOGEN ACTIVATOR INHIBITOR 1; PAI1
176947 ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70
179520 RAS-RELATED PROTEIN 1A; RAP1A
202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
203300 HERMANSKY-PUDLAK SYNDROME; HPS
208900 ATAXIA-TELANGIECTASIA; AT
209850 AUTISTIC DISORDER
251000 METHYLMALONICACIDURIA DUE TO METHYLMALONIC CoA MUTASE DEFICIENCY
261650 PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL; PCK2
261680 PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1
300053 SYNAPTOBREVIN-LIKE 1; SYBL1
300188 TRINUCLEOTIDE REPEAT-CONTAINING GENE 11; TNRC11
309850 MONOAMINE OXIDASE A; MAOA
600085 PROTEIN-TYROSINE KINASE SYK; SYK
600446 ADENOSINE A2B RECEPTOR; ADORA2B
600456 NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2
600554 INTERLEUKIN 15; IL15
600665 MELATONIN RECEPTOR 1A; MTNR1A
600807 ASTHMA
601021 NUCLEOPORIN, 98-KD; NUP98
601115 GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3
601814 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2
602260 PERIOD, DROSOPHILA, HOMOLOG OF; PER1
602359 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1
602705 SYNAPSIN III; SYN3
602893 KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4
603023 ZINC FINGER PROTEIN, SUBFAMILY 1A, MEMBER 1; ZNFN1A1
603302 ADENYLATE CYCLASE 9; ADCY9
603348 HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A
603401 ADAPTIN, BETA-3A; AP3B1
603597 SUPPRESSOR OF CYTOKINE SIGNALING 1
603968 POLYMERASE, DNA, ETA; POLH
604099 GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2
604126 SUPERVILLIN; SVIL
604982 HERMANSKY-PUDLAK SYNDROME GENE 1; HPS1
604996 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3
605474 TOLL-LIKE RECEPTOR 9; TLR9
606118 HERMANSKY-PUDLAK SYNDROME GENE 3; HPS3
606678 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8;
606681 NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
606683 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6

February 8, 2002

Changed Entries:

114480 BREAST CANCER
123900 VILLIN 2; VIL2
126375 DNA METHYLTRANSFERASE 1; DNMT1
141900 HEMOGLOBIN--BETA LOCUS; HBB
142994 HOMEO BOX GENE HB9; HLXB9
159991 MYOGENIC FACTOR 6; MYF6
172420 PHOSPHOLIPASE C, GAMMA-1; PLCG1
176450 CURRARINO SYNDROME
182160 SIALOPHORIN; SPN
228000 FARBER LIPOGRANULOMATOSIS
251000 METHYLMALONICACIDURIA DUE TO METHYLMALONIC CoA MUTASE DEFICIENCY
309845 MOESIN; MSN
601056 BCL2-RELATED PROTEIN A1; BCL2A1
602172 CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1; CYP8B1
604896 MCKUSICK-KAUFMAN SYNDROME GENE; MKKS
605446 RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
605476 PHOSPHOINOSITIDE 3-KINASE ENHANCER
Clinical Synopsis for 273800 THROMBASTHENIA OF GLANZMANN AND NAEGELI
Clinical Synopsis for 303350 MASA SYNDROME
Clinical Synopsis for 601803 PALLISTER-KILLIAN SYNDROME; PKS

February 7, 2002

New Entries:

606665 OPSIN 4; OPN4

Changed Entries:

104219 ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D
104221 ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A
104222 MOVED TO 104219
124092 INTERLEUKIN 10; IL10
138160 SOLUTE CARRIER FAMILY 2, MEMBER 2; SLC2A2
150292 LAMININ, GAMMA-2; LAMC2
150310 LAMININ, BETA-3; LAMB3
160781 MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2
163890 SYNUCLEIN, ALPHA; SNCA
168600 PARKINSON DISEASE; PD
182870 SPECTRIN, BETA, ERYTHROCYTIC; SPTB
185880 VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VAMP1
186590 SYNTAXIN 1A; STX1A
226650 EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE
227810 FANCONI-BICKEL SYNDROME; FBS
229300 FRIEDREICH ATAXIA 1; FRDA
310200 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER
600140 CREB-BINDING PROTEIN; CREBBP
600322 SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25
601179 RAS-RELATED NUCLEAR PROTEIN; RAN
601180 RAN-BINDING PROTEIN 1; RANBP1
601937 NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3
602303 p300/CBP-ASSOCIATED FACTOR; PCAF
602362 GTPase-ACTIVATING PROTEIN, RAN, 1; RANGAP1
604420 HEMATOPOIETICALLY EXPRESSED HOMEO BOX; HHEX
604439 GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1
605242 USHER SYNDROME TYPE IC GENE; USH1C
605417 DICKKOPF, XENOPUS, HOMOLOG OF, 4; DKK4
606203 GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2
606650 GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A
606651 GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B

February 6, 2002

New Entries:

606678 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8;
606679 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5;
606680 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6;

Changed Entries:

105400 AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
107748 APEX NUCLEASE; APEX
118200 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B; CMT1B
118220 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
119530 OROFACIAL CLEFT 1; OFC1
120140 COLLAGEN, TYPE II, ALPHA-1; COL2A1
134790 FERRITIN LIGHT CHAIN; FTL
137192 GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3
151660 LIPODYSTROPHY, FAMILIAL PARTIAL; FPLD
152430 LONGEVITY
168000 PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1; PGL1
182870 SPECTRIN, BETA, ERYTHROCYTIC; SPTB
190000 TRANSFERRIN; TF
191342 UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1; UCHL1
213300 JOUBERT SYNDROME 1; JBTS1
220290 DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 1; DFNB1
232300 GLYCOGEN STORAGE DISEASE II
250250 CARTILAGE-HAIR HYPOPLASIA; CHH
300276 ECTODYSPLASIN RECEPTOR, X-LINKED
305100 ECTODERMAL DYSPLASIA 1, ANHIDROTIC; ED1
313700 ANDROGEN RECEPTOR; AR
314850 KELL BLOOD GROUP PRECURSOR; XK
600046 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600315 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4; TNFRSF4
600435 CARDIOTROPHIN 1; CTF1
600886 HYPERFERRITINEMIA-CATARACT SYNDROME
601620 T-BOX 5; TBX5
602026 PHYTANOYL-CoA HYDROXYLASE; PHYH
602322 TELOMERASE RNA COMPONENT; TERC
602690 SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN;
603090 UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3
604373 CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2
604418 GAP JUNCTION PROTEIN, BETA-6; GJB6
604824 KLOTHO; KL
605131 WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX
605211 BARH-LIKE 1; BARHL1
606256 STATURE QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 7

February 5, 2002

New Entries:

606674 INFLAMMATORY BOWEL DISEASE 6; IBD6
606675 INFLAMMATORY BOWEL DISEASE 4; IBD4
606676 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2;
606677 DENDRITIC CELL LECTIN

Changed Entries:

116899 CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A
120435 COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1
120436 COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2
125480 MAJOR AFFECTIVE DISORDER 1; MAFD1
137350 GELSOLIN; GSN
141900 HEMOGLOBIN--BETA LOCUS; HBB
143100 HUNTINGTON DISEASE; HD
147683 INTERLEUKIN 13; IL13
147781 INTERLEUKIN 4 RECEPTOR; IL4R
159980 MYOGENIC FACTOR 4; MYOG
160900 DYSTROPHIA MYOTONICA 1
162200 NEUROFIBROMATOSIS, TYPE I; NF1
165161 ONCOGENE JUN-B; JUNB
176807 PROSTATE CANCER
180069 RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65
180300 RHEUMATOID ARTHRITIS
180435 RIBONUCLEASE L; RNASEL
188840 TITIN; TTN
190070 V-KI-RAS2 KIRSTEN RAT SARCOMA 2 VIRAL ONCOGENE HOMOLOG; KRAS2
190685 DOWN SYNDROME
242650 PRIMARY CILIARY DYSKINESIA; PCD
244400 KARTAGENER SYNDROME
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1
300237 TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1
300334 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5;
314670 X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
400000 AZOOSPERMIA FACTOR 2; AZF2
590105 TRANSFER RNA, MITOCHONDRIAL, VALINE; MTTV
600702 SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
600807 ASTHMA
600855 DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A
600985 TENASCIN-XB; TNXB
601518 PROSTATE CANCER, HEREDITARY, 1; HPC1
601763 CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8
602343 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1;
602345 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3;
602812 H3 HISTONE FAMILY, MEMBER C; H3FC
603335 DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5
603651 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4;
603652 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6;
604145 CARDIOMYOPATHY, DILATED, 1G; CMD1G
604396 SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1
604705 MER TYROSINE KINASE PROTOONCOGENE; MERTK
604774 ANGIOPOIETIN-LIKE 3; ANGPTL3
605377 DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
605692 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7;
606621 ESTROGEN-RELATED RECEPTOR-BETA-LIKE 1; ESRRBL1
606632 ODOR, MALE, WOMEN'S CHOICE OF

February 4, 2002

New Entries:

606673 BETA-UREIDOPROPIONASE; UPB1

Changed Entries:

106150 ANGIOTENSIN I; AGT
115150 CARDIOFACIOCUTANEOUS SYNDROME
126453 DOPAMINE RECEPTOR D5; DRD5
146928 INTERLEUKIN 8 RECEPTOR, BETA; IL8RB
147870 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2
162200 NEUROFIBROMATOSIS, TYPE I; NF1
164975 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A; WNT5A
165330 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3; WNT3
166200 OSTEOGENESIS IMPERFECTA, TYPE I
186973 T-CELL TYROSINE KINASE EMT; EMT
191321 UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52
209850 AUTISTIC DISORDER
210100 BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF
212750 CELIAC DISEASE; CD
213700 CEREBROTENDINOUS XANTHOMATOSIS
215700 CITRULLINEMIA, CLASSIC
219700 CYSTIC FIBROSIS; CF
229050 FOLIC ACID, TRANSPORT DEFECT INVOLVING
261550 PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
264080 PROGESTERONE RESISTANCE; PGR
300248 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE
300291 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY
301500 FABRY DISEASE
305100 ECTODERMAL DYSPLASIA 1, ANHIDROTIC; ED1
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1; CSNB1
311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
600130 APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1
600678 MutS, E. COLI, HOMOLOG OF, 6; MSH6
600957 ANTI-MULLERIAN HORMONE; AMH
600983 NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2
601098 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C; CMT1C
601570 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A; WNT7A
602016 KRUPPEL-LIKE FACTOR 2; KLF2
602096 ALZHEIMER DISEASE, FAMILIAL, TYPE 5
603348 HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A
603349 ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1
603490 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4
604663 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6; WNT6
605498 M-PHASE PHOSPHOPROTEIN 1; MPHOSPH1
605923 SRY-BOX 8; SOX8
606352 ALSIN
606361 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B; WNT5B
606603 EDAR-ASSOCIATED DEATH DOMAIN; EDARADD
606663 LYSYL OXIDASE-LIKE 2; LOXL2
606667 G PROTEIN-COUPLED RECEPTOR 49; GPR49

February 1, 2002

New Entries:

606671 ALL1-FUSED GENE FROM CHROMOSOME 3p21

Changed Entries:

120210 COLLAGEN, TYPE IX, ALPHA-1; COL9A1
126060 DIHYDROFOLATE REDUCTASE; DHFR
126448 MOVED TO 126453
126453 DOPAMINE RECEPTOR D5; DRD5
142702 HISTATIN 3; HTN3
158343 ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1
176872 MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1
601064 ZINC FINGER PROTEIN 36, C3H TYPE-LIKE 1; ZFP36L1
601814 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2
602359 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1
604996 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3
605523 TRANSDUCER OF ERBB2, 1; TOB1
605608 CLAUDIN 14; CLDN14
605706 ANKYRIN REPEAT DOMAIN 3; ANKRD3
606641 BODY MASS INDEX
606642 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 7
606643 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 13
606669 FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5; FXYD5
Clinical Synopsis for 602080 PAGET DISEASE OF BONE; PDB

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH